CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Nektar Therapeutics announced inducement stock option grants of 25,200 shares to employees under Nasdaq Listing Rule 5635(c)(4) on August 20, 2026.

Importance:1/10
Sentiment:
0.00
Inducement GrantsStock OptionsCompensationCorporate Governance
Related Companies

Read the original article

Published by PR Newswire Biotech on August 28, 2026 8:15 PM

Read Original